ELLEN HOLM: Open Payments
NPI 1942606413 · BETTENDORF, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 31 payments from 14 companies in 2025. Trend: 2023 $578 · 2024 $912 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $170 |
| Calliditas Therapeutics US Inc. | 1 | $99 |
| Travere Therapeutics, Inc. | 4 | $95 |
| ABBVIE INC. | 2 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Ardelyx, Inc. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: Fabhalta, TARPEYO, EMBLAVEO, Kerendia, IBSRELA, JARDIANCE, GATTEX, JYNARQUE.
Industry payments across IA — which companies pay providers there.
